Fri, August 2, 2019
Thu, August 1, 2019
Wed, July 31, 2019

Joel Beatty Upgraded (VNDA) to Strong Buy and Held Target at $19 on, Aug 1st, 2019

Joel Beatty of Citigroup, Upgraded "Vanda Pharmaceuticals Inc." (VNDA) to Strong Buy and Held Target at $19 on, Aug 1st, 2019.

Joel, nor any peers, have made any analyst calls on VNDA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30